In these gray areas, an advisory committee can be essential; it allows for a real-time debate on the benefit-risk profile ...

Shah Capital plans “against” votes on directors and say-on-pay, while seeking to sway ISS and Glass Lewis rather than running ...

Companion diagnostics (CDx), positioned at the intersection of pathology, drug development, and patient access, have emerged ...

U.S. District Judge David Joseph, a Trump appointee sitting in Lafayette, Louisiana, refused Louisiana Attorney General Liz ...

GLP-1 drugs continue to dominate the pharmaceutical landscape. The medication is popular for its weight loss applications, ...

The most immediate impacts of the U.S.- Iran conflict is being observed in the supply of active pharmaceutical ingredients ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...

Copay misuse at the pharmacy isn't always intentional, but the cost to your program is the same either way. Cindy Baksh, ConnectiveRx, discusses pharma's shift from reactive audits to real-time ...

Gilead Sciences agreed to acquire Tubulis GmbH for upwards of $5 billion in a deal that significantly expands Gilead's oncology pipeline and establishes Munich as a dedicated antibody-drug conjugates ...

Novo Nordisk’s U.S. launch of a higher-dose Wegovy formulation highlights Novo's effort to extend efficacy, capture broader patient demand, and reinforce its dominance in the rapidly expanding obesity ...

Intensifying pipeline competition and shorter differentiation windows demand faster, higher-precision launch decisions as most products fail to reach “international excellence” and many generate ...

World Health Day 2026’s theme of “Together for health, Stand with science,” arrives at a moment when scientific evidence is being tested across public health policy and drug development.